Literature DB >> 22302675

What is the Functional Role of N-terminal Transmembrane Helices in the Metabolism Mediated by Liver Microsomal Cytochrome P450 and its Reductase?

Daniel Andrew Gideon1, Rashmi Kumari, Andrew M Lynn, Kelath Murali Manoj.   

Abstract

We sought to clarify on the hitherto unresolved role of N-terminal transmembrane segments (TMS) of cytochrome P450 (CYP) and its' reductase (CPR) in protein interaction/catalysis. TMS analyses show little evolutionary conservation in CYPs. The conserved CPR's TMS poses limited scope for predictable/consistent hetero-recognition with the wide bevy of CYPs' TMS, as evident from preliminary analyses and TMhit server predictions for inter-helical binding. Further, experimentations with four different CPR preparations (preps) and two liver microsomal CYPs (2C9 and 2E1) shows that the hydroxylated product formation rate is not quantitatively correlated to the extent of integrity of the CPR N-terms. Incorporation of cytochrome b (5) in some reactions afforded similar rates while employing either fully intact or partially intact CPR. A survey of literature shows that liver microsomal CYPs function quite well even without the TMS or with significantly altered TMS. These observations negate the hypothesis that N-term TMS of CPR or CYP is obligatory for CYP-CPR interaction and catalysis. Also, in CYP2E1-mediated hydroxylation of para-nitrophenol, the extent of intactness or truncation did not significantly affect the CPR preps' catalytic role at very low or high substrate concentrations. To interpret these results, we draw support from recently published research on reduced nicotinamide adenide dinucleotide phosphate oxidase (Takac et al., J Biol Chem, 286:13304-13313, 2011) and from our pertinent earlier works. We infer that CPR' free TMS segment could alter the diffusible reactive oxygen species' dynamics in the microenvironment, thereby altering the reaction outcome. Based on the evidence, we conclude that TMS merely facilitates "interaction/catalysis" by anchoring the CYP and CPR in the lipid interface.

Entities:  

Year:  2012        PMID: 22302675     DOI: 10.1007/s12013-012-9339-0

Source DB:  PubMed          Journal:  Cell Biochem Biophys        ISSN: 1085-9195            Impact factor:   2.194


  10 in total

1.  Probing the transmembrane structure and dynamics of microsomal NADPH-cytochrome P450 oxidoreductase by solid-state NMR.

Authors:  Rui Huang; Kazutoshi Yamamoto; Meng Zhang; Nataliya Popovych; Ivan Hung; Sang-Choul Im; Zhehong Gan; Lucy Waskell; Ayyalusamy Ramamoorthy
Journal:  Biophys J       Date:  2014-05-20       Impact factor: 4.033

2.  Expression of flavonoid 6-hydroxylase candidate genes in normal and mutant soybean genotypes for glycitein content.

Authors:  Marie-Pierre Artigot; Mathieu Baes; Jean Daydé; Monique Berger
Journal:  Mol Biol Rep       Date:  2013-05-22       Impact factor: 2.316

3.  Functioning of drug-metabolizing microsomal cytochrome P450s: In silico probing of proteins suggests that the distal heme 'active site' pocket plays a relatively 'passive role' in some enzyme-substrate interactions.

Authors:  Avanthika Venkatachalam; Abhinav Parashar; Kelath Murali Manoj
Journal:  In Silico Pharmacol       Date:  2016-02-19

Review 4.  Regulation of Human Cytochrome P4501A1 (hCYP1A1): A Plausible Target for Chemoprevention?

Authors:  Rebeca Santes-Palacios; Diego Ornelas-Ayala; Noel Cabañas; Ana Marroquín-Pérez; Alexis Hernández-Magaña; Sitlali Del Rosario Olguín-Reyes; Rafael Camacho-Carranza; Jesús Javier Espinosa-Aguirre
Journal:  Biomed Res Int       Date:  2016-12-26       Impact factor: 3.411

Review 5.  Tripping the light fantastic in membrane redox biology: linking dynamic structures to function in ER electron transfer chains.

Authors:  Tobias M Hedison; Nigel S Scrutton
Journal:  FEBS J       Date:  2019-01-30       Impact factor: 5.542

6.  Corrigendum: The Role of the FMN-Domain of Human Cytochrome P450 Oxidoreductase in Its Promiscuous Interactions With Structurally Diverse Redox Partners.

Authors:  Francisco Esteves; Diana Campelo; Bruno Costa Gomes; Philippe Urban; Sophie Bozonnet; Thomas Lautier; José Rueff; Gilles Truan; Michel Kranendonk
Journal:  Front Pharmacol       Date:  2020-05-21       Impact factor: 5.810

7.  The curious case of benzbromarone: insight into super-inhibition of cytochrome P450.

Authors:  Abhinav Parashar; Sudeep Kumar Gade; Mahesh Potnuru; Nandita Madhavan; Kelath Murali Manoj
Journal:  PLoS One       Date:  2014-03-03       Impact factor: 3.240

8.  Co-expression of active human cytochrome P450 1A2 and cytochrome P450 reductase on the cell surface of Escherichia coli.

Authors:  Paul Quehl; Joel Hollender; Jan Schüürmann; Tatjana Brossette; Ruth Maas; Joachim Jose
Journal:  Microb Cell Fact       Date:  2016-02-02       Impact factor: 5.328

9.  Functioning of Microsomal Cytochrome P450s: Murburn Concept Explains the Metabolism of Xenobiotics in Hepatocytes.

Authors:  Kelath Murali Manoj; Abhinav Parashar; Sudeep K Gade; Avanthika Venkatachalam
Journal:  Front Pharmacol       Date:  2016-06-23       Impact factor: 5.810

10.  Murburn Concept: A Molecular Explanation for Hormetic and Idiosyncratic Dose Responses.

Authors:  Abhinav Parashar; Daniel Andrew Gideon; Kelath Murali Manoj
Journal:  Dose Response       Date:  2018-05-09       Impact factor: 2.658

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.